VMP 318121006

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-amilozide 2.5mg/25mg tablets
BNF code 0202040C0AAABAB
Virtual Therapeutic Moiety Co-amilozide
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-amilozide 2.5/25 tablets
Basis of previous name BAN - British Approved Name
Reason for name change
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Hydrochlorothiazide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Amiloride hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 2.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-amilozide 2.5mg/25mg tablets (A A H Pharmaceuticals Ltd)
Co-amilozide 2.5mg/25mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amilozide 2.5mg/25mg tablets (DE Pharmaceuticals)
Co-amilozide 2.5mg/25mg tablets (Medihealth (Northern) Ltd)
Co-amilozide 2.5mg/25mg tablets (Phoenix Healthcare Distribution Ltd)
Co-amilozide 2.5mg/25mg tablets (Sigma Pharmaceuticals Plc)
Co-amilozide 2.5mg/25mg tablets (Tillomed Laboratories Ltd)
Co-amilozide 2.5mg/25mg tablets (Wockhardt UK Ltd)
Virtual Medicinal Product Packs
Co-amilozide 2.5mg/25mg tablets 100 tablet
Co-amilozide 2.5mg/25mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.4.0_20211129000001, imported on 30th November 2021 at 04:13:28.